Ezgi Yenişekerci Kulak

Dr. Ezgi Yenişekerci Kulak

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2019 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
DEDiğdem Özer Etik
Diğdem Özer Etik
NSNuretdin Suna
Nuretdin Suna
CGCemre Gündüz
Cemre Gündüz
ABAhmet Bostan
Ahmet Bostan
AÖAlperen Özdemir
Alperen Özdemir
ABAhmet Sedat Boyacıoğlu
Ahmet Sedat Boyacıoğlu
Background/Aims: A successful screening colonoscopy is closely linked to the quality of a bowel preparation. In this study, we aimed to determine the impact of a 1-day clear liquid diet (CLD) compared to a 3-day combined diet (CMD) accompanied by a split-dose regimen of polyethylene glycol and electrolyte lavage solution (PEG-ELS) for screening colonoscopy. Materials and Methods: This was a prospective, randomized, endoscopist-blinded study. Patients referred for screening colonoscopy were randomized to four groups as a 1-day CLD+PEG-ELS vs. a 1-day CLD+sulfate free (SF)-PEG-ELS and a 3-day CMD+PEG-ELS vs. a 3-day CMD+SF-PEG-ELS. An assessment of the quality of colon cleaning, tolerability to the preparation, and symptoms related to the preparation were recorded. Results: A total of 506 patients were enrolled in this study. The quality of bowel preparation was significantly inferior in the CMD+PEG-ELS group than CLD+PEG-ELS (p=0.004) and CMD+SF-PEG-ELS groups (p=0.007). There were no statistical differences among the groups in terms of the polyp detection rate. With respect to an easy rating of diet following and the consumption of laxative, there were no significant differences among the four groups. Gastric fullness and nausea/vomiting were pointed out much more, especially in the SF-PEG-ELS users (p=0.008 and p=0.004, respectively). Conclusion: A 1-day CLD was not inferior to a 3-day CMD for colonoscopy preparation in terms of bowel cleaning, the polyp detection rate, and patient tolerance.

8 August 2026 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
BTBusra Turkmen
Busra Turkmen
MYMerve Özel Yetkin
Merve Özel Yetkin
EKEzgi Yenişekerci Kulak
Ezgi Yenişekerci Kulak
GBGulden Baskol
Gulden Baskol
MBMevlut Baskol
Mevlut Baskol

9 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ACAyse NURANSOY Cengiz
Ayse NURANSOY Cengiz
MCMuhammet Cengi̇z
Muhammet Cengi̇z
OBOKTAY BOZKURT
OKTAY BOZKURT
GZGozde Erturk Zararsiz
Gozde Erturk Zararsiz
AEAleyna Erakcaoğlu
Aleyna Erakcaoğlu
MOMetin Ozkan
Metin Ozkan
Background/Objectives: Therapeutic options for metastatic breast cancer vary according to hormone receptor (HR) status, human epidermal growth factor receptor 2 (HER2) status, and, importantly, the newly recognized HER2-low status. In triple-negative breast cancer (TNBC), characterized by the absence of HR and HER2 receptors, therapeutic approaches and survival rates differ significantly. Current treatments have improved survival rates in metastatic diseases, resulting in an increased demand for secondary biopsies. The findings from these biopsies affect the range of therapeutic options. Methods: The data of 172 patients with metastatic breast cancer were retrospectively analyzed. The initial and subsequent biopsy specimens from these patients were compared. Their effects on survival and prognosis were analyzed statistically. Results: Overall, 12.8% of patients transitioned to triple-negative status. Upon analysis of HER2-low status, 13.4% of patients initially classified as HER2-negative transitioned to HER2-low status. The median overall survival was 26 months (95% CI: 19.1–32.8) in the HR-concordant group and 21 months (95% CI: 14.3–27.6) in the HR-discordant group (p < 0.03). Conclusions: The present study clarifies the rates of HR and HER2 receptor concordance and discordance in metastatic breast cancer. It provides a comprehensive dataset that incorporates all receptors and TNBC transformation. Furthermore, it demonstrates conversion to HER2-low status and examines the implications of TNBC transformation and HR discordance on prognosis and survival.